|
English
Start » Veröffentlichungen
Liste der Veröffentlichungen
Aktualisiert: Mai 2010
| 1996 |
|
|
|
[1] |
A. Hueber
In-situ-Darstellung von messenger-Ribonukleinsäure,
Peptid und Rezeptor des basischen Fibroblasten-
Wachstumsfaktors in intravitrealen Traktionsmembranen
bei proliferativen Netzhauterkrankungen.
Promotion, Universität zu Köln, 1996
|
| 1997 |
|
|
|
[2] |
A. Hueber, P. Wiedemann, P. Esser und K. Heimann
Basic fibroblast growth factor mRNA, bFGF peptide
and FGF receptor in epiretinal membranes of intraocular
proliferative disorders (PVR and PDR).
Int Ophthalmol 20(6):345-50, 1997
|
|
|
|
|
[3] |
P. Esser, S. Grisanti, N. Kociok, H. Abts, A. Hueber,
K. Unfried, K. Heimann und M. Weller
Expression and upregulation of microtubule-associated
protein 1B in cultured retinal pigment epithelial cells.
Invest Ophthalmol Vis Sci 38(13):2852-6, 1997
|
| 1998 |
|
|
|
[4] |
A. Hueber, S. Winter und M. Weller
Chemotherapy primes malignant glioma cells for CD95
ligand-induced apoptosis up-stream of caspase 3 activation.
Eur J Pharmacol 352(1):111-5, 1998
|
|
|
|
|
[5] |
A. Hueber, P. Esser, K. Heimann, N. Kociok, S. Winter und M. Weller
The topoisomerase I inhibitors, camptothecin and
beta-lapachone, induce apoptosis of human retinal pigment
epithelial cells.
Exp Eye Res 67(5):525-30, 1998
|
|
|
|
|
[6] |
A. Hueber, S. Durka und M. Weller
CD95-mediated apoptosis: no variation in cellular
sensitivity during cell cycle progression.
FEBS Lett 432(3):155-7, 1998
|
| 2000 |
|
|
|
[7] |
J. Esser, P. Esser, H. Mietz, A. Hueber, N. Kociok,
U. Schraermeyer und G.K. Krieglstein
Multidrug resistance-associated proteins in glaucoma surgery.
Graefes Arch Clin Exp Ophthalmol 238(9):727-32, 2000
|
| 2002 |
|
|
|
[8] |
A. Hueber, G. Welsandt, F.J. Jordan, H. Mietz, M. Weller,
G.K. Krieglstein und P.J. Esser
Characterization of CD95 ligand (CD95L)-induced apoptosis
in human tenon fibroblasts.
Exp Eye Res 75(1):1-8, 2002
|
|
|
|
|
[9] |
A. Hueber, S. Aduckathil, N. Kociok, G. Welsandt, S. Dinslage,
B. Kirchhof und P.J. Esser
Apoptosis-mediating receptor-ligand systems in human
retinal pigment epithelial cells.
Graefes Arch Clin Exp Ophthalmol 240(7):551-6, 2002
|
|
|
|
|
[10] |
N. Kociok, A. Hueber, P. Esser, U. Schraermeyer, G. Thumann,
T.T. Luther, J. Jordan, G. Welsandt und B. Kirchhof
Vitreous Treatment of Cultured Human RPE Cells Results
in Differential Expression of 10 New Genes.
Invest Ophthalmol Vis Sci 43(7):2474-80, 2002
|
| 2003 |
|
|
|
[11] |
A. Hueber, C.D. Eichholtz, N. Kociok, J.M. Esser und P.J. Esser
Lens epithelial cells express CD95 and CD95 ligand treatment
induces cell death and DNA fragmentation in vitro.
Eur J Ophthalmol 13(3):241-5, 2003
|
|
|
|
|
[12] |
A. Hueber, M. Weller, G. Welsandt, N. Kociok, B. Kirchhof und P. Esser
Characterization of daunorubicin-induced apoptosis in retinal
pigment epithelial cells: Modulation by CD95L.
Invest Ophthalmol Vis Sci 44(7):2851-7, 2003
|
|
|
|
|
[13] |
H. Mietz, J. Esser, G. Welsandt, N. Kociok, A. Hueber, A. Joussen, P.J. Esser und
G.K. Krieglstein
Latanoprost Stimulates Secretion of Matrix Metalloproteinases
in Conjunctival Fibroblasts Both in-vitro and in-vivo.
Invest Ophthalmol Vis Sci 44(12):5182-8, 2003
|
| 2004 |
|
|
|
[14] |
S. Dinslage, A. Hueber, M. Diestelhorst und G.K. Krieglstein
The influence of Latanoprost 0.005% on aqueous humor flow
and outflow facility in glaucoma patients: a double-masked
placebo-controlled clinical study.
Graefes Arch Clin Exp Ophthalmol 242:654-60, 2004
|
| 2005 |
|
|
|
[15] |
A. Hueber, S. Grisanti und M. Diestelhorst
Photodynamic Therapy for Wound Healing Modulation in
Pterygium Surgery. A Clinical Pilot Study.
Graefes Arch Clin Exp Ophthalmol 243(9):942-6, 2005
|
|
|
|
|
[16] |
A. Hueber, M. Lüke, P.J. Esser, B. Kirchhof, W. Sickel und C. Lüke
Effects of daunorubicin and CD95L on retinal function in
superfused vertebrate retina.
J Ocul Pharmacol Ther 21(2):133-8, 2005
|
|
|
|
|
[17] |
C. Lüke, M. Lüke, T.S. Dietlein, A. Hueber, J. Jordan, W. Sickel und B. Kirchhof
Retinal tolerance to dyes.
Br J Ophthalmol 89(9):1188-91, 2005
|
|
|
|
|
[18] |
A. Hueber
Neue Ansätze zur medikamentösen Therapie der proliferativen Vitreoretinopathie. In-vitro Studien.
Habilitation, Universität zu Köln, 2005
|
| 2006 |
|
|
|
[19] |
G. Thumann, A. Hueber, S. Dinslage, F. Schaefer, T. Yasukawa, B. Kirchhof, Y. Yafai, W. Eichler, A. Bringmann und P. Wiedemann
Characteristics of iris and retinal pigment epithelial cells cultured on collagen type I membranes.
Curr Eye Res 31(3):241-9, 2006
|
|
|
|
|
[20] |
A. Hueber
Filterkissenvernarbung: Gibt es neue Therapiemöglichkeiten?
Ophthalmologische Nachrichten 09(DOG-Kongressausgabe 1):19, 2006
|
|
|
|
|
[21] |
A.M. Schild, A. Hueber, T.S. Dietlein und G.K. Krieglstein
Unilateraler Hemiarcus lipoides corneae nach Filtrationschirurgie.
Ophthalmologe 103(10):895-897, 2006
|
| 2007 |
|
|
|
[22] |
G. Welsandt, A. Hueber, T.S. Dietlein, S. Roters
Schwere Verätzung durch Planzensaft.
Zeitschrift für praktische Augenheilkunde 28: 107-109, 2007
|
|
|
|
|
[23] |
H. Mietz, G. Welsandt, A. Hueber, C. Esser, G.K. Krieglstein
Synergistic effects of combined cytotoxic and apoptosis-inducing drugs on Tenon's capsule fibroblasts in vitro and in vivo.
Graefes Arch Clin Exp Ophthalmol 245(9):1367-75, 2007
|
| 2008 |
|
|
|
[24] |
A. Hueber, J.M. Esser, N. Kociok, G. Welsandt, C. Lüke, S. Roters, P.J. Esser
Mitomycin C induces multidrug resistance in glaucoma surgery.
Graefes Arch Clin Exp Ophthalmol 246(2):297-304, 2008
|
| 2009 |
|
|
|
[25] |
A. Hueber, W. Konen, C.P. Jonescu-Cuypers, G.K. Krieglstein
IOL-Stärkenprofile in Deutschland
Der Augenspiegel 55(07-08):24-25, 2009
|
|